Healthy Volunteers Under Fasting Conditions clinical trials

Explore recruiting healthy volunteers under fasting conditions clinical trials.

Recruiting healthy volunteers under fasting conditions studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Healthy Volunteers Under Fasting Conditions trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, open-label, single dose, two-period, cross-over bioequivalence study comparing test formulation Rosuvastatin/Amlodipine/Ramipril capsule, hard 10mg/5mg/5mg versus reference products Crestor 10 mg film coated tablets, Norvasc 5 mg tablets, Tritace 5 mg tablets in healthy male and female subjects under fasting conditions. Sponsor’s Study Number: ROS-AML-RAM-BIO-02-23

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A single dose, randomized, open-label, three-way crossover study to assess bioequivalence of paracetamol orodispersible tablets 500 mg vs Apiretal® 100 mg/ml oral solution in healthy volunteers under fasting conditions

Spain

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Comparative Bioavailability of Midazolam 7.5 mg/1.5 mL Oromucosal Solution (Buccolam®) Versus Midazolam 10 mg/2 mL Solution for Injection (Hypnovel®): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.

Portugal

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

RANDOMISED, CROSSOVER BIOEQUIVALENCE CLINICAL TRIAL OF LINAGLIPTIN 5 MG FILM-COATED TABLETS, AFTER A SINGLE ORAL DOSE ADMINISTRATION TO HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS

Spain

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Randomised, crossover bioequivalence clinical trial of hydrochlorothiazide 25 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions.

Spain

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Randomised, crossover bioequivalence clinical trial of apixabán 5 mg film coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.

Spain

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Healthy Volunteers Under Fasting Conditions trials by city

Healthy Volunteers Under Fasting Conditions in Toronto Healthy Volunteers Under Fasting Conditions in Vancouver Healthy Volunteers Under Fasting Conditions in Montreal Healthy Volunteers Under Fasting Conditions in Calgary Healthy Volunteers Under Fasting Conditions in Edmonton Healthy Volunteers Under Fasting Conditions in Ottawa Healthy Volunteers Under Fasting Conditions in Winnipeg Healthy Volunteers Under Fasting Conditions in Quebec City Healthy Volunteers Under Fasting Conditions in Hamilton Healthy Volunteers Under Fasting Conditions in Kitchener Healthy Volunteers Under Fasting Conditions in London Healthy Volunteers Under Fasting Conditions in Halifax Healthy Volunteers Under Fasting Conditions in New York Healthy Volunteers Under Fasting Conditions in Los Angeles Healthy Volunteers Under Fasting Conditions in Chicago Healthy Volunteers Under Fasting Conditions in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease